[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100270690":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":34,"responsibleParty":47,"collaborators":18,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":18,"enrollmentInfo":60,"targetDuration":18,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":18,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Aortic Stenosis\u002Fregurgitation","EXPERIMENTAL","Transcatheter aortic valve replacement",[13],"Procedure: transcatheter aortic valve replacement",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":18},"PROCEDURE","transcatheter aortic valve replacement",null,[9],[21],{"name":22,"affiliation":23,"role":24},"Jian-an Wang, MD,PhD","Second Affiliated Hospital of Zhejiang University School of Medicine","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":18,"email":30},"Xianbao Liu, MD","CONTACT","+86-13857173887","liuxb2009@hotmail.com",{"name":22,"role":28,"phone":32,"phoneExt":18,"email":33},"+86-13805786328","Wang_jian_an@tom.com",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":18,"geoPoint":18,"contacts":43},"The Second Affiliated Hospital, School of Medicine at Zhejiang University","RECRUITING","Hanzhou","Zhejiang","310000","China","CN",[44],{"name":45,"role":28,"phone":18,"phoneExt":18,"email":46},"Xianbao Liu, PHD","liuxb@zju.edu.cn",{"type":24,"investigatorFullName":48,"investigatorTitle":49,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Jian'an Wang,MD,PhD","President of Second Affiliated Hospital, School of Medicine, Zhejiang University & Chief of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University","100270690","phase-4-transcatheter-aortic-valve-replacement-single-center-registry-in-chinese-population-100270690",false,"NCT02803294","Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population","THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population","TORCH","Inclusion Criteria:\n\n* Patients with symptomatic aortic stenosis\u002Fregurgitation\n* Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent.\n* The subject agrees to comply with specified follow-up evaluations and to return to the investigational site where the procedure was performed.\n* Patients are technical and anatomical eligible for interventions\n\nExclusion Criteria:\n\n* A known hypersensitivity or contraindication to any of the following which cannot be adequately pre-medicated: Aspirin Heparin (HIT\u002FHITTS) and bivalirudin Nitinol (titanium or nickel) Ticlopidine and clopidogrel Contrast media\n* Subject refuses a blood transfusion.\n* Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the subject from appropriate consent.\n* Life expectancy is less than one year","ALL","18 Years",{"count":61,"type":62},2000,"ESTIMATED","INTERVENTIONAL",[65],"PHASE4","The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.",[68],"Symptomatic Aortic Stenosis","2021-07-14",{"date":71,"type":72},"2021-07-15","ACTUAL",{"date":74,"type":18},"2016-06",{"date":76,"type":62},"2027-07",{"name":5,"class":6},1]